Ray Dalio Quest Diagnostics Inc Transaction History

Bridgewater Associates, LP

$17.3 Billion
Q3 2024

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Bridgewater Associates, LP holds 88,739 shares of DGX stock, worth $12.2 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

88,739

Previous 143,718 38.25%

Holding current value

$12.2 Million

Previous $19.7 Million 38.16%

% of portfolio

0.07%

Previous 0.1%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$137.09 - $137.09 $7.54 Million - $7.54 Million	-54,979 Reduced 38.25%	88,739 $12.2 Million
Q2 2024 Aug 14, 2024	SELL	$125.91 - $144.34 $6.81 Million - $7.81 Million	-54,083 Reduced 27.34%	143,718 $19.7 Million
Q1 2024 May 14, 2024	SELL	$123.78 - $142.11 $470,240 - $539,875	-3,799 Reduced 1.88%	197,801 $26.3 Million
Q4 2023 Feb 14, 2024	SELL	$120.62 - $141.12 $5.36 Million - $6.27 Million	-44,452 Reduced 18.07%	201,600 $27.8 Million
Q3 2023 Nov 13, 2023	BUY	$121.86 - $144.92 $13 Million - $15.5 Million	106,639 Added 76.49%	246,052 $30 Million
Q2 2023 Aug 11, 2023	SELL	$130.56 - $146.84 $1.19 Million - $1.34 Million	-9,108 Reduced 6.13%	139,413 $19.6 Million
Q1 2023 May 12, 2023	SELL	$131.53 - $155.76 $6.12 Million - $7.24 Million	-46,502 Reduced 23.84%	148,521 $21 Million
Q4 2022 Feb 13, 2023	BUY	$123.31 - $157.26 $4.16 Million - $5.3 Million	33,728 Added 20.91%	195,023 $30.5 Million
Q3 2022 Nov 10, 2022	SELL	$121.77 - $141.1 $1.7 Million - $1.97 Million	-13,962 Reduced 7.97%	161,295 $19.8 Million
Q2 2022 Aug 11, 2022	BUY	$127.07 - $145.39 $536,235 - $613,545	4,220 Added 2.47%	175,257 $23.3 Million
Q1 2022 May 13, 2022	BUY	$129.09 - $164.35 $3.83 Million - $4.87 Million	29,631 Added 20.95%	171,037 $23.4 Million
Q4 2021 Feb 14, 2022	BUY	$140.36 - $173.01 $1.23 Million - $1.52 Million	8,794 Added 6.63%	141,406 $24.5 Million
Q3 2021 Nov 12, 2021	BUY	$132.95 - $158.0 $505,209 - $600,400	3,800 Added 2.95%	132,612 $19.3 Million
Q2 2021 Aug 13, 2021	BUY	$126.66 - $141.48 $8.44 Million - $9.43 Million	66,636 Added 107.17%	128,812 $17 Million
Q1 2021 May 14, 2021	SELL	$114.63 - $133.34 $638,145 - $742,303	-5,567 Reduced 8.22%	62,176 $7.98 Million
Q4 2020 Feb 12, 2021	BUY	$112.7 - $128.05 $3.93 Million - $4.46 Million	34,860 Added 106.01%	67,743 $8.07 Million
Q3 2020 Nov 13, 2020	BUY	$107.05 - $130.01 $3 Million - $3.64 Million	28,005 Added 574.11%	32,883 $3.77 Million
Q2 2020 Aug 12, 2020	SELL	$73.34 - $122.61 $177,629 - $296,961	-2,422 Reduced 33.18%	4,878 $556,000
Q1 2020 May 14, 2020	BUY	$75.14 - $115.68 $548,522 - $844,464	7,300 New	7,300 $586,000
Q3 2019 Nov 13, 2019	SELL	$97.85 - $107.42 $3.41 Million - $3.74 Million	-34,817 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$85.18 - $101.94 $1.66 Million - $1.99 Million	-19,541 Reduced 35.95%	34,817 $3.55 Million
Q1 2019 May 14, 2019	SELL	$80.68 - $89.92 $7.05 Million - $7.86 Million	-87,368 Reduced 61.65%	54,358 $4.89 Million
Q4 2018 Feb 13, 2019	BUY	$79.75 - $108.38 $8.65 Million - $11.8 Million	108,465 Added 326.1%	141,726 $11.8 Million
Q3 2018 Nov 13, 2018	BUY	$105.42 - $114.99 $706,946 - $771,122	6,706 Added 25.25%	33,261 $3.59 Million
Q2 2018 Aug 13, 2018	SELL	$97.35 - $113.14 $9.01 Million - $10.5 Million	-92,574 Reduced 77.71%	26,555 $0
Q1 2018 May 15, 2018	BUY	$96.42 - $107.88 $9.5 Million - $10.6 Million	98,569 Added 479.42%	119,129 $11.9 Million
Q4 2017 Feb 13, 2018	SELL	$90.86 - $100.24 $17 Million - $18.8 Million	-187,561 Reduced 90.12%	20,560 $2.03 Million
Q3 2017 Nov 13, 2017	BUY	$91.96 - $108.35 $19.1 Million - $22.5 Million	208,121	208,121 $19.5 Million

Others Institutions Holding DGX

# of Institutions

923

Shares Held

95M

Call Options Held

379K

Put Options Held

354K

View Full List

About QUEST DIAGNOSTICS INC

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

More about DGX

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account